Derivatives Expected To Get Green Light In European Funds

  • 08 Dec 2003
Email a colleague
Request a PDF

After months of wrangling the European Commission is expected to say derivatives can be used for limited borrowing and leverage in certain Europe-wide funds. This will be a boon for the derivatives industry, especially because it was feared that European regulators were attempting to tighten the rules. "This is what the industry was hoping for," said one equity derivatives structurer. Calls to the Commission were not returned by press time.

A group of national regulators known as the Contact Committee is due to meet with the European Commission this week and are expected to give the most favorable interpretation of the rule, known as UCITS 3 (Undertakings for Collective Investment in Transferable Securities). Officials familiar with the EC say that preliminary meetings show the body is likely to approve the committee's work.

The dispute over what types and how many derivatives can be used in UCITS funds centers around whether a specific paragraph that says collective investment vehicles can use derivatives should be seen in the wider context of UCITS 3, which says funds cannot borrow or leverage.

  • 08 Dec 2003

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 276,777.40 1064 8.14%
2 JPMorgan 266,530.47 1166 7.84%
3 Bank of America Merrill Lynch 250,764.41 839 7.38%
4 Barclays 205,469.94 758 6.05%
5 Goldman Sachs 184,785.44 600 5.44%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 35,188.43 145 6.49%
2 JPMorgan 32,762.25 63 6.04%
3 UniCredit 29,291.42 133 5.40%
4 SG Corporate & Investment Banking 28,951.69 110 5.34%
5 Credit Agricole CIB 26,611.53 134 4.91%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 11,195.88 46 9.03%
2 Goldman Sachs 10,193.27 47 8.22%
3 Citi 9,056.44 50 7.31%
4 Morgan Stanley 6,436.97 42 5.19%
5 UBS 6,389.02 24 5.15%